Breast Cancer With Bone Mets: Less Zoledronic Acid Is FineBreast Cancer With Bone Mets: Less Zoledronic Acid Is Fine

Women with breast cancer and bone metastasis can scale back on the use of a bone-building drug over time and apparently still get the same benefit, new research suggests. Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news